Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiocarcinoma | 3 | 2022 | 36 | 1.590 |
Why?
|
| Bile Duct Neoplasms | 3 | 2022 | 60 | 1.550 |
Why?
|
| Isocitrate Dehydrogenase | 5 | 2026 | 28 | 1.470 |
Why?
|
| Neoplasms | 4 | 2025 | 1376 | 1.030 |
Why?
|
| Tumor Microenvironment | 5 | 2026 | 183 | 0.990 |
Why?
|
| Citric Acid Cycle | 1 | 2025 | 29 | 0.910 |
Why?
|
| Immune Evasion | 1 | 2024 | 71 | 0.800 |
Why?
|
| Dioxygenases | 2 | 2022 | 36 | 0.740 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2018 | 84 | 0.660 |
Why?
|
| Cell Polarity | 2 | 2018 | 110 | 0.580 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2018 | 9 | 0.580 |
Why?
|
| GTP Phosphohydrolases | 1 | 2018 | 64 | 0.550 |
Why?
|
| Immunity, Innate | 1 | 2024 | 829 | 0.550 |
Why?
|
| Stem Cells | 1 | 2018 | 276 | 0.490 |
Why?
|
| Neoplastic Stem Cells | 4 | 2015 | 196 | 0.490 |
Why?
|
| Biliary Tract Neoplasms | 2 | 2026 | 10 | 0.470 |
Why?
|
| Glutarates | 2 | 2026 | 11 | 0.450 |
Why?
|
| Bile Ducts, Intrahepatic | 3 | 2022 | 29 | 0.400 |
Why?
|
| Mutation | 5 | 2026 | 2670 | 0.380 |
Why?
|
| Head and Neck Neoplasms | 2 | 2011 | 166 | 0.370 |
Why?
|
| Immunotherapy | 2 | 2026 | 274 | 0.360 |
Why?
|
| Cell Line, Tumor | 7 | 2026 | 1573 | 0.350 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 264 | 0.350 |
Why?
|
| Mice | 11 | 2026 | 11173 | 0.340 |
Why?
|
| Liver Neoplasms | 2 | 2025 | 308 | 0.330 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 71 | 0.320 |
Why?
|
| Animals | 12 | 2026 | 21459 | 0.310 |
Why?
|
| Mitochondria | 2 | 2026 | 413 | 0.280 |
Why?
|
| DNA Methylation | 3 | 2026 | 306 | 0.270 |
Why?
|
| Humans | 21 | 2026 | 65645 | 0.260 |
Why?
|
| Proteomics | 2 | 2026 | 299 | 0.240 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2026 | 39 | 0.240 |
Why?
|
| Lipid Peroxidation | 1 | 2026 | 67 | 0.230 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2026 | 33 | 0.230 |
Why?
|
| MicroRNAs | 3 | 2018 | 714 | 0.220 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2025 | 5 | 0.220 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2025 | 5 | 0.220 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2025 | 9 | 0.220 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 47 | 0.220 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 408 | 0.220 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 1226 | 0.220 |
Why?
|
| DNA Demethylation | 1 | 2024 | 3 | 0.210 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 64 | 0.210 |
Why?
|
| Tumor Escape | 1 | 2024 | 16 | 0.210 |
Why?
|
| Signal Transduction | 4 | 2025 | 3162 | 0.210 |
Why?
|
| Thiadiazoles | 1 | 2023 | 3 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2023 | 3 | 0.200 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2023 | 14 | 0.200 |
Why?
|
| Naphthalenes | 1 | 2023 | 17 | 0.200 |
Why?
|
| Nucleotidyltransferases | 1 | 2024 | 66 | 0.200 |
Why?
|
| Alkylating Agents | 1 | 2023 | 10 | 0.190 |
Why?
|
| DNA Transposable Elements | 1 | 2024 | 160 | 0.190 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2025 | 175 | 0.190 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2024 | 71 | 0.190 |
Why?
|
| Melanoma | 1 | 2026 | 334 | 0.180 |
Why?
|
| CTLA-4 Antigen | 1 | 2022 | 72 | 0.180 |
Why?
|
| Biology | 1 | 2022 | 25 | 0.180 |
Why?
|
| RNA | 1 | 2025 | 427 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 446 | 0.170 |
Why?
|
| Cell Line | 2 | 2018 | 2029 | 0.170 |
Why?
|
| Mammary Glands, Animal | 1 | 2020 | 76 | 0.160 |
Why?
|
| Estrogens | 1 | 2020 | 115 | 0.150 |
Why?
|
| Interferon-gamma | 1 | 2022 | 576 | 0.150 |
Why?
|
| DNA | 1 | 2024 | 853 | 0.150 |
Why?
|
| Estradiol | 1 | 2020 | 260 | 0.150 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 36 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2020 | 344 | 0.140 |
Why?
|
| Transcription Factors | 2 | 2025 | 1559 | 0.140 |
Why?
|
| Breast Neoplasms | 3 | 2020 | 1233 | 0.140 |
Why?
|
| Mice, Knockout | 2 | 2020 | 2168 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2020 | 1389 | 0.120 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2015 | 37 | 0.110 |
Why?
|
| Histocompatibility Antigens | 1 | 2015 | 107 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 1 | 2015 | 70 | 0.110 |
Why?
|
| Leptin | 1 | 2015 | 89 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2014 | 55 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2026 | 218 | 0.100 |
Why?
|
| Cell Movement | 2 | 2011 | 482 | 0.090 |
Why?
|
| Obesity | 2 | 2023 | 1277 | 0.090 |
Why?
|
| src-Family Kinases | 1 | 2011 | 64 | 0.090 |
Why?
|
| Gene Expression Profiling | 2 | 2015 | 797 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2011 | 344 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2011 | 189 | 0.080 |
Why?
|
| Mice, Nude | 1 | 2010 | 287 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2026 | 1042 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2025 | 679 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 297 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 869 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2010 | 664 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 898 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2026 | 963 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 593 | 0.070 |
Why?
|
| Female | 5 | 2026 | 34309 | 0.060 |
Why?
|
| RNA Interference | 1 | 2010 | 647 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2026 | 52 | 0.060 |
Why?
|
| Isotope Labeling | 1 | 2025 | 69 | 0.060 |
Why?
|
| Jurkat Cells | 1 | 2025 | 109 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2026 | 328 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2025 | 129 | 0.050 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2026 | 269 | 0.050 |
Why?
|
| Synthetic Lethal Mutations | 1 | 2024 | 4 | 0.050 |
Why?
|
| Carnitine | 1 | 2024 | 19 | 0.050 |
Why?
|
| Glycolysis | 1 | 2024 | 59 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2015 | 135 | 0.050 |
Why?
|
| Arylsulfotransferase | 1 | 2023 | 1 | 0.050 |
Why?
|
| Sulfotransferases | 1 | 2023 | 9 | 0.050 |
Why?
|
| Interferons | 1 | 2023 | 74 | 0.050 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2022 | 5 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 205 | 0.050 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2023 | 89 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2023 | 220 | 0.050 |
Why?
|
| Immune System | 1 | 2023 | 132 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 588 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2022 | 144 | 0.040 |
Why?
|
| ErbB Receptors | 1 | 2022 | 128 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2022 | 198 | 0.040 |
Why?
|
| Endocrine System | 1 | 2020 | 16 | 0.040 |
Why?
|
| Estrogen Receptor alpha | 1 | 2020 | 49 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2020 | 282 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 2326 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2015 | 15 | 0.030 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 65 | 0.030 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2015 | 29 | 0.030 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2014 | 6 | 0.030 |
Why?
|
| Transcription Factor HES-1 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Receptor, Notch2 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Jagged-1 Protein | 1 | 2014 | 8 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2014 | 8 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 36 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 48 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2014 | 95 | 0.030 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2014 | 157 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 277 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2011 | 6 | 0.020 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 28 | 0.020 |
Why?
|
| Clone Cells | 1 | 2011 | 111 | 0.020 |
Why?
|
| Rats | 1 | 2015 | 1996 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2011 | 289 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 324 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 205 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2014 | 925 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1193 | 0.020 |
Why?
|
| Apoptosis | 1 | 2011 | 1100 | 0.020 |
Why?
|